CIPO Patents = 4

Forward Citations = 1

Loading Chart...

4 inventors (with patents filed for the assignee):

Pei Kan (5 out of 10 patents)

Yi Fong Lin (5 out of 7 patents)

Ko Chieh Chen (5 out of 6 patents)

5 patents: Sort by Forward Citations

1. 12220483 - Liposome compositions comprising weak acid drugs and uses thereof (2025-02-11),

2. 12064406 - Pharmaceutical composition of a weak acid drug and methods of administration (2024-08-20),

3. 11964050 - Liposome compositions comprising weak acid drugs and uses thereof (2024-04-23),

4. 11833125 - Pharmaceutical composition for controlled release of treprostinil (2023-12-05),

5. 11229616 - Pharmaceutical composition for controlled release of treprostinil (2022-01-25),

Pharmosa Biopharm Inc. is a leading biopharmaceutical company specializing in the development of innovative therapies for various diseases. With a strong focus on research and development, we are dedicated to bringing new and improved treatments to patients worldwide. Our team of experts is committed to advancing healthcare through cutting-edge science and technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#786 in Taipei

#2,270 in Taiwan

Taipei, Taiwan

Pharmosa Biopharm Inc.

Forward Citations = 1

4 inventors:

Pei Kan (5 out of 10 patents)

Yi Fong Lin (5 out of 7 patents)

Ko Chieh Chen (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

4 patents (CIPO):

Please report any incorrect information to support@idiyas.com